Dr Reddy's shares gain over 1% after Nomura retains 'Buy'; Rs1,740 target, key biologics milestones ahead

Shares of Dr Reddy's Laboratories gained over 1% on September 28 after Nomura retained its 'Buy' rating and Rs1,740 target price, with the brokerage highlighting key upcoming milestones for the company's biologics business.The stock of Dr Reddy's was trading at Rs1,213.60 on the NSE at 9:34 am, up…